Travis J. Bjordahl, Dds, Pllc | |
1203 E 4th Ave Ste 103 Milbank SD 57252-1558 | |
(605) 432-5032 | |
(605) 432-4844 |
Full Name | Travis J. Bjordahl, Dds, Pllc |
---|---|
Speciality | Clinic/center - Dental |
Location | 1203 E 4th Ave Ste 103, Milbank, South Dakota |
Authorized Official Name and Position | Travis Bjordahl (OWNER) |
Authorized Official Contact | 6054325032 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Travis J. Bjordahl, Dds, Pllc Po Box 592 Milbank SD 57252-0592 Ph: (605) 432-5032 | Travis J. Bjordahl, Dds, Pllc 1203 E 4th Ave Ste 103 Milbank SD 57252-1558 Ph: (605) 432-5032 |
NPI Number | 1518425552 |
---|---|
Provider Enumeration Date | 03/08/2019 |
Last Update Date | 03/08/2019 |
Identifier | Type | State | Issuer |
---|---|---|---|
1518425552 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
News Archive
The use of electronic cigarettes, battery operated devices that often look like cigarettes and deliver vaporized nicotine, is on the rise, including among minors. In a survey between 2011 and 2012, 10 percent of high school students reported ever using an e-cigarette.
Janssen-Cilag Ltd today announced that NHS England will provide crucial funding for its once-daily, fixed-dose combination of darunavir and the pharmacoenhancer, cobicistat, called REZOLSTA.
Thomas Jefferson University Hospitals recently extended licensing agreements with TeleTracking Technologies for automated patient flow solutions and added TeleTracking's Bed Management Suite™ at its Methodist campus.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.
› Verified 1 days ago
Mark A Bierschbach D.d.s., P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1203 East 4th Ave., Suite 103, Milbank, SD 57252 Phone: 605-432-5032 Fax: 605-432-4844 | |
Bryan C. Johnson, Dds, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 309 S Main St, Milbank, SD 57252 Phone: 605-432-9531 Fax: 605-432-4830 |